| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
786,383 |
|
|
Indirect Shares
|
362,461 |
|
|
| Direct
Value |
$788,702,830 |
|
|
|
Indirect Value
|
$363,530,260 |
|
|
| Total
Shares |
1,148,844 |
|
|
| Total
Value |
$1,152,233,090 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-05-16 |
786,383 |
2024-05-16 |
362,461 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-12-12 |
4 |
D |
$377.16 |
$47,964,192 |
D/D |
(127,172) |
444,109 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-03-09 |
4 |
D |
$476.42 |
$61,420,543 |
D/D |
(128,921) |
635,614 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2012-02-15 |
4 |
OE |
$8.50 |
$1,133,322 |
D/D |
133,332 |
901,079 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2011-11-30 |
4 |
D |
$58.19 |
$8,304,993 |
D/D |
(142,722) |
926,983 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-02-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
150,722 |
753,316 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-02-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
150,722 |
249,278 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-02-15 |
4 |
OE |
$399.66 |
$69,030,474 |
D/D |
172,723 |
925,209 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-07-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
176,223 |
331,629 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-07-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
176,223 |
323,777 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-08-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
176,223 |
176,223 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-08-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
176,223 |
155,406 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2015-10-30 |
4 |
OE |
$11.64 |
$2,128,002 |
D/D |
182,818 |
682,818 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-02-11 |
4 |
OE |
$9.49 |
$1,798,004 |
D/D |
189,463 |
1,257,806 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2013-05-06 |
4 |
OE |
$13.00 |
$2,500,004 |
D/D |
192,308 |
1,309,638 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2016-12-15 |
4 |
OE |
$20.32 |
$3,964,005 |
D/D |
195,079 |
697,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CSO |
• • – |
2017-12-13 |
4 |
OE |
$21.92 |
$4,284,001 |
D/D |
195,438 |
786,786 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2011-11-30 |
4 |
OE |
$28.01 |
$5,602,000 |
D/D |
200,000 |
928,701 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-06-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
211,585 |
213,693 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-06-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
211,585 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-12-30 |
4 |
D |
$483.25 |
$104,773,433 |
D/D |
(216,810) |
822,207 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO Pres Regen Res Labs |
• • – |
2012-12-17 |
4 |
D |
$179.13 |
$42,728,775 |
D/D |
(238,535) |
1,066,484 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
242,150 |
847 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-12-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
242,150 |
486,820 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2018-12-13 |
4 |
OE |
$16.80 |
$4,100,006 |
D/D |
244,048 |
167,185 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-12-12 |
4 |
OE |
$21.25 |
$5,212,519 |
D/D |
245,295 |
521,876 |
0 |
- |
|
145 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
